XML 60 R45.htm IDEA: XBRL DOCUMENT v3.22.4
OPERATING SEGMENTS AND GEOGRAPHIC INFORMATION (Tables)
12 Months Ended
Dec. 31, 2022
OPERATING SEGMENTS AND GEOGRAPHIC INFORMATION  
Schedule of financial information for each of the entity's reportable segments, including the impact of the preceding changes on previously reported full year 2021 net sales and operating income

December 31, 2021

  

  

  

  

2021 Reported

Fixed

2021 Reported

Valued at 2021

  

  

Currency

  

Valued at 2022

(millions)

Management Rates

  

Other

  

Rate Change

  

Management Rates

Net Sales

  

  

  

Global Industrial

$6,304.9

$-

($218.1)

$6,086.8

Global Institutional & Specialty

3,978.2

-

(69.4)

3,908.8

Global Healthcare & Life Sciences

1,195.4

-

(45.8)

1,149.6

Other

1,226.9

-

(25.9)

1,201.0

Corporate

139.4

-

(2.0)

137.4

Subtotal at fixed currency rates

12,844.8

-

(361.2)

12,483.6

Effect of foreign currency translation

(111.7)

-

361.2

249.5

Consolidated reported GAAP net sales

$12,733.1

$-

$-

$12,733.1

Operating Income

Global Industrial

$1,031.0

$4.0

($49.3)

$985.7

Global Institutional & Specialty

556.9

(3.8)

(7.4)

545.7

Global Healthcare & Life Sciences

160.9

(0.9)

(7.7)

152.3

Other

187.3

0.7

(4.0)

184.0

Corporate

(318.6)

-

2.0

(316.6)

Subtotal at fixed currency rates

1,617.5

-

(66.4)

1,551.1

Effect of foreign currency translation

(18.9)

-

66.4

47.5

Consolidated reported GAAP operating income

$1,598.6

$-

$-

$1,598.6

December 31, 2020

  

2020 Reported

  

  

Fixed

  

2020 Reported

Valued at 2021

  

Segment

  

Currency

  

Valued at 2022

(millions)

Management Rates

  

Change

  

Rate Change

  

Management Rates

Net Sales

  

  

  

Global Industrial

$6,048.2

$-

($202.5)

$5,845.7

Global Institutional & Specialty

3,629.0

-

(69.2)

3,559.8

Global Healthcare & Life Sciences

1,241.1

-

(51.0)

1,190.1

Other

1,103.4

-

(23.6)

1,079.8

Corporate

100.6

-

(1.2)

99.4

Subtotal at fixed currency rates

12,122.3

-

(347.5)

11,774.8

Effect of foreign currency translation

(332.1)

-

347.5

15.4

Consolidated reported GAAP net sales

$11,790.2

$-

$-

$11,790.2

Operating Income

Global Industrial

$1,123.1

$1.4

($45.4)

$1,079.1

Global Institutional & Specialty

324.0

(1.6)

(6.1)

316.3

Global Healthcare & Life Sciences

218.3

(0.5)

(10.2)

207.6

Other

132.8

0.7

(2.9)

130.6

Corporate

(349.7)

-

2.0

(347.7)

Subtotal at fixed currency rates

1,448.5

-

(62.6)

1,385.9

Effect of foreign currency translation

(52.8)

-

62.6

9.8

Consolidated reported GAAP operating income

$1,395.7

$-

$-

$1,395.7

Schedule of financial information for each of the entity's reportable segments

Net Sales

Operating Income (Loss)

(millions)

2022

2021

2020

2022

2021

2020

Global Industrial

$6,944.0

$6,086.8

$5,845.7

$977.0

$985.7

$1,079.1

Global Institutional & Specialty

4,480.0

3,908.8

3,559.8

634.5

545.7

316.3

Global Healthcare & Life Sciences

1,570.0

1,149.6

1,190.1

205.0

152.3

207.6

Other

1,355.0

1,201.0

1,079.8

212.8

184.0

130.6

Corporate

124.1

137.4

99.4

(416.7)

(316.6)

(347.7)

Subtotal at fixed currency

14,473.1

12,483.6

11,774.8

1,612.6

1,551.1

1,385.9

Effect of foreign currency translation

(285.3)

249.5

15.4

(50.1)

47.5

9.8

Consolidated reported GAAP

$14,187.8

$12,733.1

$11,790.2

$1,562.5

$1,598.6

$1,395.7

Schedule of net sales and long-lived assets at public exchange rates by geographic region

Long-Lived Assets, net

(millions)

2022

    

2021

 

United States

$2,508.9

$2,416.4

Europe

 

574.3

580.7

Asia Pacific

210.3

237.1

Greater China

 

176.6

186.4

Latin America

 

146.5

137.9

India, Middle East and Africa

64.1

60.2

Canada

 

60.9

66.5

Total

$3,741.6

$3,685.2